Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Oct 1, 2019
Date Accepted: Mar 16, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
WeChat as a Platform for Problem-Based Learning：towards to exploring new teaching methods for hematological postgraduate
ABSTRACT
Hematological medicine is a practical discipline that difficult to study. The cultivation for postgraduate majored in hematology is rather hard. Problem-based learning (PBL) is a student-centered innovating teaching method that students define their own learning objectives from clinically based problem. It has been widely accepted in student-centered medical education. Owing to the geographic and time dispersion of the students, traditional PBL has its own limitations. WeChat, the most popular platform among university students in China, was introduced in hematology teaching. In this study, we combine traditional PBL and WeChat together to explore a new WeChat Problem-Based learning mode for postgraduate majored in hematology. 100 questionnaires were distributed to evaluate how the students and tutors think about the WeChat-PBL teaching mode. The data showed that the WeChat-PBL teaching mode was popular and widely accepted. Our new PBL mode is time saving, convenience and easy to conduct. It emphasizes interoperable, interactive, effective and more participatory. We firmly believe that using this new WeChat-PBL teaching model will certainly help students be more excellent.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.